Ergebnisseite 11 für Wirtschaftszweig: Gesundheitswesen Branche: Biotechnologie Aktienmarkt – Aktienkurse & Preise
Liste aller Aktien und Wertpapiere mit Preisen, Marktkapitalisierungen, KGV und EPS
Alle Länder
- {{country.name}}
- Alle Länder
- Vereinigte Staaten (1012)
- Australien (58)
- Österreich (16)
- Belgien (7)
- Brasilien (16)
- Kanada (83)
- China (92)
- Dänemark (6)
- Finnland (4)
- Frankreich (41)
- Deutschland (738)
- Hongkong (46)
- Indien (19)
- Irland (1)
- Israel (19)
- Italien (4)
- Japan (37)
- Mexiko (28)
- Niederlande (3)
- Neuseeland (1)
- Norwegen (14)
- Polen (9)
- Russland (2)
- Südkorea (12)
- Spanien (4)
- Schweden (70)
- Schweiz (11)
- Taiwan (67)
- Thailand (2)
- Türkei (1)
- Vereinigtes Königreich (69)
Alle Börsen
- {{item.name}}
- Alle Börsen
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (289)
- NasdaqGM (143)
- NasdaqGS (218)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (119)
- OTC Markets OTCPK (134)
- OTC Markets OTCQB (33)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (45)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Gesundheitswesen (2608)
- {{item.name}}
- Alle Bereiche
- Gesundheitswesen (2608)
Biotechnologie (2608)
- {{item.name}}
- Alle Branchen
- Biotechnologie (2608)
- Arzneimittelhersteller-Allgemeines (265)
- Arzneimittelherstellern-Spezielle und Generische (1632)
- Gesundheitsprogrammen (57)
- Medizinische Versorgungseinrichtungen (554)
- Pharmazeutischen Einzelhändler (155)
- Gesundheitsinformationsdienste (419)
- Medizinische Geräte (916)
- Medizinische Geräte und Materialien (501)
- Medizinische Diagnostik und Forschung (429)
- Medizinische Vertrieb (138)
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS |
|---|
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,072,000 809.18 USD |
-0.74
|
$76.3T 57.59B USD | $23.9K 18.04 USD | $1,062,000 801.64 USD | $1,084,000 818.24 USD | $76.3T 57.59B USD | 0 | $0 0 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $483.3 528.31 USD |
+3.51
|
$51.3B 56.08B USD | $0 0 USD | $469.6 513.34 USD | $483.3 528.31 USD | $51.3B 56.08B USD | 14.23 | $33.96 37.12 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $85.74 17.38 USD |
0
|
$227.98B 46.21B USD | $0 0 USD | $0 0 USD | $0 0 USD | $227.98B 46.21B USD | 0 | -$0.57 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $125.4 25.42 USD |
+6.31
|
$193.26B 39.17B USD | $0 0 USD | $0 0 USD | $0 0 USD | $193.26B 39.17B USD | 35.12 | $3.57 0.72 USD | |
| UCB SA UCBJF | $203.85 — |
0
|
$38.74B — | $1 — | $198.15 — | $198.15 — | $38.74B — | 31.75 | $6.42 — | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $269.9 295.04 USD |
+0.63
|
$35.41B 38.7B USD | $375 409.93 USD | $269.9 295.04 USD | $269.9 295.04 USD | $35.41B 38.7B USD | 0 | -$1.83 -2.0004 USD | |
| UCB SA UCB.VI | $172.1 188.13 USD |
+2.62
|
$32.71B 35.75B USD | $0 0 USD | $172 188.02 USD | $172.85 188.95 USD | $32.71B 35.75B USD | 30.89 | $5.57 6.09 USD | |
| UCB SA UNC.F | $170.4 186.27 USD |
+0.09
|
$32.38B 35.4B USD | $310 338.87 USD | $170.4 186.27 USD | $170.4 186.27 USD | $32.38B 35.4B USD | 31.20 | $5.46 5.97 USD | |
| UCB SA UNC0.F | $84 91.82 USD |
+0.6
|
$32.29B 35.3B USD | $50 54.66 USD | $84 91.82 USD | $84 91.82 USD | $32.29B 35.3B USD | 30.65 | $2.74 3 USD | |
| argenx SE ARGNF | $547.6 — |
0
|
$33.51B — | $3 — | $532.4 — | $547.18 — | $33.51B — | 33.45 | $16.37 — | |
| argenx SE ARGX.VI | $471.5 515.41 USD |
+1.84
|
$29.09B 31.8B USD | $0 0 USD | $471 514.87 USD | $471.7 515.63 USD | $29.09B 31.8B USD | 33.70 | $13.99 15.29 USD | |
| argenx SE 1AEA.F | $466 509.4 USD |
+2.64
|
$28.96B 31.66B USD | $12 13.12 USD | $466 509.4 USD | $466 509.4 USD | $28.96B 31.66B USD | 32.88 | $14.17 15.49 USD | |
| argenx SE 1AE.F | $469.7 513.45 USD |
+2.69
|
$28.82B 31.5B USD | $5 5.47 USD | $465 508.31 USD | $469.7 513.45 USD | $28.82B 31.5B USD | 32.93 | $14.26 15.59 USD | |
| BioNTech SE B1NT34.SA | $39.2 7.95 USD |
+2.73
|
$151.45B 30.7B USD | $0 0 USD | $0 0 USD | $0 0 USD | $151.45B 30.7B USD | 0 | -$1.27 -0.2 USD | |
| Celltrion, Inc. 068270.KS | $178,000 134.36 USD |
-0.34
|
$40.3T 30.42B USD | $150.6K 113.68 USD | $176,300 133.08 USD | $180,000 135.87 USD | $40.3T 30.42B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
0
|
$25.73B 28.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $25.73B 28.13B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49BA.F | $218 238.3 USD |
+0.93
|
$24.6B 26.89B USD | $10 10.93 USD | $218 238.3 USD | $218 238.3 USD | $24.6B 26.89B USD | 0 | -$3 -3.2 USD | |
| BioNTech SE 22UA.F | $97.1 106.14 USD |
+0.88
|
$23.34B 25.52B USD | $642 701.79 USD | $94.7 103.52 USD | $97.1 106.14 USD | $23.34B 25.52B USD | 0 | -$3.18 -3.4 USD | |
| BioNTech SE BNTX.VI | $96.85 105.87 USD |
+1.31
|
$23.28B 25.45B USD | $0 0 USD | $95.5 104.39 USD | $96.85 105.87 USD | $23.28B 25.45B USD | 0 | -$3.18 -3.4 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $30.76 33.62 USD |
+2.47
|
$17.42B 19.05B USD | $114 124.62 USD | $30.2 33.01 USD | $30.76 33.62 USD | $17.42B 19.05B USD | 14.71 | $2.09 2.28 USD | |
| Royalty Pharma plc RPD.MU | $30.59 33.44 USD |
0
|
$16.98B 18.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $16.98B 18.56B USD | 14.63 | $2.09 2.28 USD | |
| Insmed Incorporated IM8N.SG | $81.5 89.09 USD |
-1.21
|
$15.63B 17.09B USD | $0 0 USD | $81.5 89.09 USD | $81.5 89.09 USD | $15.63B 17.09B USD | 0 | -$5 -5.4 USD | |
| Insmed Incorporated IM8N.F | $81 88.54 USD |
-0.61
|
$15.44B 16.88B USD | $550 601.22 USD | $81 88.54 USD | $81 88.54 USD | $15.44B 16.88B USD | 0 | -$5.09 -5.5 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Genmab A/S 0MGB.IL | $1,394.5 204.46 USD |
+2.25
|
$111.67B 16.37B USD | $56 8.21 USD | $0 0 USD | $0 0 USD | $111.67B 16.37B USD | 19.70 | $70.77 10.38 USD | |
| Innovent Biologics, Inc. 6IB.F | $8.65 9.46 USD |
-2.81
|
$14.79B 16.16B USD | $100 109.31 USD | $8.6 9.4 USD | $8.8 9.62 USD | $14.79B 16.16B USD | 0 | -$0.01 -0.01 USD | |
| Incyte Corporation INCY.MX | $1,306.32 77.35 USD |
0
|
$252.86B 14.97B USD | $0 0 USD | $1,306.32 77.35 USD | $1,306.32 77.35 USD | $252.86B 14.97B USD | 344.67 | $3.79 0.22 USD | |
| Moderna, Inc. MRNA.MX | $638 37.78 USD |
+6.87
|
$247.77B 14.67B USD | $2.23K 131.81 USD | $616.01 36.48 USD | $638 37.78 USD | $247.77B 14.67B USD | 0 | -$165.5 -9.8 USD | |
| Incyte Corporation I1NC34.SA | $185.15 37.53 USD |
0
|
$71.68B 14.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $71.68B 14.53B USD | 336.63 | $0.55 0.11 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.7099 — |
+4.4
|
$13.48B — | $7.41K — | $0.7199 — | $0.7299 — | $13.48B — | 71.20 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $13.92 — |
0
|
$13.47B — | $44 — | $13.8 — | $13.8 — | $13.47B — | 48.00 | $0.29 — | |
| WuXi Biologics (Cayman) WXIBF | $3.22 — |
+1.26
|
$13.39B — | $300 — | $3.18 — | $3.18 — | $13.39B — | 29.27 | $0.11 — | |
| Genmab A/S GNMSF | $215 — |
+8.31
|
$13.25B — | $2 — | $205 — | $205 — | $13.25B — | 12.60 | $17.05 — | |
| Verona Pharma plc I9SA.F | $88.8 97.07 USD |
-0.45
|
$11.99B 13.1B USD | $1.99K 2.17K USD | $88.4 96.63 USD | $91.6 100.13 USD | $11.99B 13.1B USD | 0 | -$1.46 -1.5 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $162.45 32.93 USD |
+2.18
|
$63.71B 12.91B USD | $0 0 USD | $0 0 USD | $0 0 USD | $63.71B 12.91B USD | 22.07 | $7.36 1.49 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,053 62.35 USD |
0
|
$213.06B 12.62B USD | $0 0 USD | $1,053 62.35 USD | $1,053 62.35 USD | $213.06B 12.62B USD | 20.96 | $50.23 2.97 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| United Therapeutics Corporation UTH.F | $253.6 277.22 USD |
+1.64
|
$11.45B 12.52B USD | $18 19.68 USD | $253.6 277.22 USD | $253.6 277.22 USD | $11.45B 12.52B USD | 12.00 | $21.12 23.09 USD | |
| Genmab A/S GMAB.VI | $185.5 202.78 USD |
+0.82
|
$11.41B 12.47B USD | $0 0 USD | $185.5 202.78 USD | $188.2 205.73 USD | $11.41B 12.47B USD | 12.89 | $14.39 15.73 USD | |
| Moderna, Inc. 0QF.F | $29.44 32.18 USD |
+4.79
|
$11.38B 12.44B USD | $1.35K 1.48K USD | $27.77 30.36 USD | $29.44 32.18 USD | $11.38B 12.44B USD | 0 | -$7.34 -8.02 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.8 3.06 USD |
+0.54
|
$11.36B 12.42B USD | $6.86K 7.5K USD | $2.75 3 USD | $2.8 3.06 USD | $11.36B 12.42B USD | 31.11 | $0.09 0.1 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.5 6.01 USD |
0
|
$11.33B 12.39B USD | $208 227.37 USD | $5.5 6.01 USD | $5.5 6.01 USD | $11.33B 12.39B USD | 30.55 | $0.18 0.2 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Moderna, Inc. MRNA.VI | $29.17 31.89 USD |
+5.54
|
$11.28B 12.33B USD | $2.16K 2.36K USD | $27.9 30.49 USD | $29.17 31.89 USD | $11.28B 12.33B USD | 0 | -$7.61 -8.3 USD | |
| Incyte Corporation ICY.F | $58.16 63.58 USD |
+1.18
|
$11.27B 12.32B USD | $198 216.44 USD | $58.16 63.58 USD | $58.16 63.58 USD | $11.27B 12.32B USD | 342.11 | $0.17 0.19 USD | |
| Moderna, Inc. 0QF.MU | $28.94 31.63 USD |
+4.33
|
$11.19B 12.23B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.19B 12.23B USD | 0 | -$6.86 -7.4 USD | |
| Akeso, Inc. 4RY.F | $11.8 12.9 USD |
0
|
$10.97B 11.99B USD | $120 131.18 USD | $11.7 12.79 USD | $12.1 13.23 USD | $10.97B 11.99B USD | 0 | -$0.07 -0.07 USD | |
| Ascendis Pharma A/S A1SN34.SA | $63.2 12.81 USD |
0
|
$57.92B 11.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $57.92B 11.74B USD | 0 | -$37.1 -7.5 USD | |
| Exelixis, Inc. EX9.F | $37.78 41.3 USD |
+2.83
|
$10.36B 11.33B USD | $1.11K 1.22K USD | $37.1 40.56 USD | $37.1 40.56 USD | $10.36B 11.33B USD | 19.98 | $1.89 2.07 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $51 55.75 USD |
-0.27
|
$9.78B 10.69B USD | $60 65.59 USD | $50.52 55.23 USD | $51 55.75 USD | $9.78B 10.69B USD | 23.28 | $2.19 2.39 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $50.74 55.47 USD |
+0.32
|
$9.73B 10.64B USD | $20 21.86 USD | $50.74 55.47 USD | $51.26 56.03 USD | $9.73B 10.64B USD | 22.15 | $2.29 2.5 USD | |
| Bio-Techne Corporation T1CH34.SA | $10.22 2.07 USD |
+7.24
|
$48.18B 9.76B USD | $0 0 USD | $0 0 USD | $0 0 USD | $48.18B 9.76B USD | 68.13 | $0.15 0.03 USD | |
| Ascendis Pharma A/S A71.F | $147 160.69 USD |
-3.29
|
$8.92B 9.75B USD | $15 16.4 USD | $147 160.69 USD | $147 160.69 USD | $8.92B 9.75B USD | 0 | -$5.69 -6.2 USD | |
| Bio-Techne Corporation TECH.MX | $976.77 57.84 USD |
-33.54
|
$155.2B 9.19B USD | $0 0 USD | $0 0 USD | $0 0 USD | $155.2B 9.19B USD | 38.45 | $25.4 1.5 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| BridgeBio Pharma, Inc. 2CL.F | $39.57 43.26 USD |
+3.75
|
$7.51B 8.21B USD | $494 540.01 USD | $38.8 42.41 USD | $39.57 43.26 USD | $7.51B 8.21B USD | 0 | -$2.95 -3.2 USD | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Bio-Techne Corporation TE1.F | $46.4 50.72 USD |
+4.98
|
$7.27B 7.95B USD | $150 163.97 USD | $44 48.1 USD | $46.4 50.72 USD | $7.27B 7.95B USD | 65.35 | $0.71 0.78 USD | |
| Blueprint Medicines Corporation 2L9.F | $109 119.15 USD |
+0.88
|
$7.11B 7.77B USD | $20 21.86 USD | $108.55 118.66 USD | $109 119.15 USD | $7.11B 7.77B USD | 0 | -$2.14 -2.3 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,018.51 60.31 USD |
0
|
$129.81B 7.69B USD | $0 0 USD | $1,018.51 60.31 USD | $1,018.51 60.31 USD | $129.81B 7.69B USD | 14.55 | $69.97 4.14 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $20.3 22.19 USD |
-0.98
|
$6.95B 7.59B USD | $10 10.93 USD | $20.3 22.19 USD | $20.3 22.19 USD | $6.95B 7.59B USD | 0 | -$4.16 -4.5 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Roivant Sciences Ltd. 87S.F | $9.45 10.33 USD |
+3.94
|
$6.52B 7.13B USD | $600 655.88 USD | $9.41 10.29 USD | $9.45 10.33 USD | $6.52B 7.13B USD | 0 | -$0.63 -0.6 USD | |
| Corcept Therapeutics Incorporated HTD.F | $61.34 67.05 USD |
+6.64
|
$6.5B 7.11B USD | $10 10.93 USD | $59.64 65.19 USD | $61.34 67.05 USD | $6.5B 7.11B USD | 61.95 | $0.99 1.08 USD | |
| 3SBio Inc. 83B.F | $2.64 2.89 USD |
-1.49
|
$6.25B 6.84B USD | $1.81K 1.98K USD | $2.58 2.82 USD | $2.64 2.89 USD | $6.25B 6.84B USD | 26.40 | $0.1 0.11 USD | |
| Legend Biotech Corporation 9LB.F | $33.8 36.95 USD |
+1.2
|
$6.22B 6.8B USD | $30 32.79 USD | $33.2 36.29 USD | $33.8 36.95 USD | $6.22B 6.8B USD | 0 | -$0.96 -1.04 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$113.36B 6.71B USD | $0 0 USD | $0 0 USD | $0 0 USD | $113.36B 6.71B USD | 0 | -$56.93 -3.3 USD | |
| Financière de Tubize SA FTD.SG | $135.4 148.01 USD |
+2.42
|
$6.11B 6.68B USD | $0 0 USD | $133.6 146.04 USD | $135.8 148.45 USD | $6.11B 6.68B USD | 67.02 | $2.02 2.21 USD | |
| ALK-Abelló A/S AKBLF | $29.52 — |
0
|
$6.66B — | $100 — | $22.35 — | $22.35 — | $6.66B — | 44.72 | $0.66 — | |
| Revolution Medicines, Inc. 42Z.F | $32.4 35.42 USD |
+5.19
|
$6.06B 6.62B USD | $100 109.31 USD | $32.4 35.42 USD | $32.4 35.42 USD | $6.06B 6.62B USD | 0 | -$3.44 -3.7 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $266.5 291.32 USD |
+1.91
|
$5.96B 6.52B USD | $17 18.58 USD | $259.7 283.89 USD | $266.5 291.32 USD | $5.96B 6.52B USD | 0 | -$14.17 -15.5 USD | |
| Financière de Tubize SA FTD.F | $133.6 146.04 USD |
-1.18
|
$5.95B 6.5B USD | $70 76.52 USD | $133.6 146.04 USD | $133.6 146.04 USD | $5.95B 6.5B USD | 65.81 | $2.03 2.22 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $48.07 52.55 USD |
+1.2
|
$5.92B 6.47B USD | $100 109.31 USD | $48.07 52.55 USD | $48.07 52.55 USD | $5.92B 6.47B USD | 15.45 | $3.11 3.4 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $96.1 105.05 USD |
+1.01
|
$5.82B 6.36B USD | $10 10.93 USD | $93.66 102.38 USD | $96.1 105.05 USD | $5.82B 6.36B USD | 15.65 | $6.14 6.71 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $36.2 39.57 USD |
-0.98
|
$5.78B 6.31B USD | $40 43.73 USD | $36.2 39.57 USD | $36.2 39.57 USD | $5.78B 6.31B USD | 0 | -$2.47 -2.7 USD | |
| ALK-Abelló A/S 4AJ0.F | $25.76 28.16 USD |
+0.62
|
$5.75B 6.28B USD | $6 6.56 USD | $25.48 27.85 USD | $25.76 28.16 USD | $5.75B 6.28B USD | 46.83 | $0.55 0.6 USD | |
| Biocon Limited BIOCON.BO | $372.4 4.51 USD |
-0.25
|
$496.99B 6.01B USD | $57.68K 697.83 USD | $370.05 4.48 USD | $377.45 4.57 USD | $496.99B 6.01B USD | 43.91 | $8.48 0.1 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $98,800 74.58 USD |
-0.2
|
$7.74T 5.84B USD | $107.62K 81.23 USD | $97,900 73.9 USD | $100,200 75.63 USD | $7.74T 5.84B USD | 0 | $0 0 USD | |
| TG Therapeutics, Inc. NKB2.F | $31.83 34.79 USD |
+5.98
|
$5.09B 5.56B USD | $300 327.94 USD | $31.83 34.79 USD | $31.83 34.79 USD | $5.09B 5.56B USD | 144.65 | $0.22 0.24 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $76.5 83.62 USD |
+26.45
|
$4.87B 5.32B USD | $1 1.09 USD | $75 81.99 USD | $76.5 83.62 USD | $4.87B 5.32B USD | 0 | -$2.23 -2.4 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $94.26 103.04 USD |
0
|
$4.69B 5.12B USD | $20 21.86 USD | $94.26 103.04 USD | $94.26 103.04 USD | $4.69B 5.12B USD | 0 | -$4.72 -5.1 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $238 34.9 USD | $0 0 USD | $0 0 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Vaxcyte, Inc. 5VA.F | $29 31.7 USD |
+7.41
|
$3.94B 4.31B USD | $100 109.31 USD | $29 31.7 USD | $29 31.7 USD | $3.94B 4.31B USD | 0 | -$3.25 -3.5 USD | |
| Genscript Biotech GNNSF | $1.95 — |
-11.36
|
$4.27B — | $1K — | $2 — | $2.05 — | $4.27B — | 0 | -$0.08 — | |
| Vaxcyte, Inc. 5VA.MU | $30.2 33.01 USD |
+6.34
|
$3.9B 4.26B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.9B 4.26B USD | 0 | -$3.31 -3.6 USD | |
|
Keine Lieblingsaktien
Sie haben noch keine Lieblingsaktie, bitte fügen Sie sie zu den Favoriten hinzu, um sie hier zu sehen |
||||||||||